Elizabeth McKenna
@ElizSMcKenna
Executive Editor of Cancer Discovery @CD_AACR, published by @AACR. @BBS_Harvard/@DanaFarber alum. Native New Yorker. Views/likes/RTs are my own. She/her
The July issue of @CD_AACR is now online! The cover features work by @alex_redding_, Elda Grabocka, and colleagues (@KimmelCancerCtr) on intercellular heterogeneity of stress granules and chemotherapy response - read that and much more: aacrjournals.org/cancerdiscover…




From the July issue: Requirement for Cyclin D1 Underlies Cell Autonomous HIF2-Dependence in Kidney Cancer brnw.ch/21wUoBl By @nitin_shirole89, @kaelin_lab, and colleagues at @DanaFarber
🧠 How does glioblastoma begin? This groundbreaking study uncovers precancerous cells as the seeds of GBM evolution—fueling heterogeneity and revealing new therapeutic targets. A must-read for neuro-oncology researchers. #Glioblastoma #CancerEvolution doi.org/10.1158/2159-8…
By @Pezcoller–@AACR Award for Extraordinary Achievement in Cancer Research winner Douglas Hanahan: HPV16-Expressing Tumors Release Multiple IL-1 Ligands to Orchestrate Systemic Immunosuppression Whose Disruption Enables Vaccine Efficacy brnw.ch/21wUmNn
Hello @ElizSMcKenna! I’m starting my lab at UCLA Bioengineering this Fall working on AI-generated proteins to understand and tackle cancer signaling. I’m more active on Bluesky btw (same username).
Hi @ElizSMcKenna! New PI from MD Anderson to the University of Colorado studying therapeutic resistance in lung cancer.
It's that time of year - roll call for all new #cancer PIs who just started or who are about to start their labs! Please say hi and what you work on so I can follow you if I don't already! 😃 #NewPI
From the July issue: Cytosolic Phospholipase A2 Determines Intercellular Heterogeneity of Stress Granules and Chemotherapy Response brnw.ch/21wUkWx By @alex_redding_, Elda Grabocka, and colleagues at @KimmelCancerCtr
Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations | Cancer Discovery | American Association for Cancer Research aacrjournals.org/cancerdiscover…
From the July issue: Activated T Cells Break Tumor Immunosuppression by Macrophage Re-education brnw.ch/21wUj8N By @RosaTrotta89, Silvia Rivis, Shikang Zhao, @LabMazzone, and colleagues at @VIB @KU_Leuven
Activated T Cells Break Tumor Immunosuppression by Macrophage Reeducation @CD_AACR aacrjournals.org/cancerdiscover…
Trends in Cancer Incidence and Mortality Rates in Early-Onset and Older-Onset Age Groups in the United States, 2010–2019 @CD_AACR aacrjournals.org/cancerdiscover…
#Precancerous Cells Initiate #Glioblastoma Evolution and Contribute to Intratumoral Heterogeneity: aacrjournals.org/cancerdiscover…
From the July issue: Precancerous Cells Initiate #Glioblastoma Evolution and Contribute to Intratumoral Heterogeneity brnw.ch/21wUdNg By Hyun Jung Kim, Jeong Ho Lee, and colleagues
By Cancer Discovery Early Career Award Winner @Sandra_Misale: Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations brnw.ch/21wUfLo
From the July issue: Trends in Cancer Incidence and Mortality Rates in Early-Onset and Older-Onset Age Groups in the United States, 2010–2019 brnw.ch/21wUc20 By @meredithshiels and colleagues @theNCI
Response and Resistance to RAS Inhibition in Cancer | Cancer Discovery | American Association for Cancer Research aacrjournals.org/cancerdiscover…
Response and Resistance to RAS Inhibition in Cancer | Cancer Discovery | American Association for Cancer Research aacrjournals.org/cancerdiscover…
Somatic Uniparental Disomy of PTEN in Endothelial Cells Causes Vascular Malformations in Patients with PTEN Hamartoma Tumor Syndrome: brnw.ch/21wUa7i By Sandra Castillo, @MarionaGraupera, and colleagues @CarrerasIJC @SJDbarcelona_es @CIBERONC @icreacommunity
Delighted that our @CD_AACR @AACR article about "The #Epigenetic Hallmarks of #Cancer" is considered a Highly Cited Paper by Essential Science Indicators Web of Science #WOS @Clarivate. Grateful to co-authors @MAF_Dawson, @CKadoch, Feyruz Rassool, Peter Jones and Steve Baylin…